Imprint Wealth’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Imprint Wealth's LLY Position: Q1 2026 in Review
Imprint Wealth reduced its Eli Lilly (LLY) stake by 17% in Q1 2026, selling an estimated $18.2K and leaving 88 shares worth $80.9K. The position accounts for 0.37% of the portfolio, ranked #47.
Imprint Wealth first reported a position in LLY in Q1 2023 and has held it in 8 quarters since. The position peaked at $3.25M in Q1 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Imprint Wealth held 88 shares of Eli Lilly worth $80.9K as of Q1 2026.
- Imprint Wealth sold 18 Eli Lilly shares in Q1 2026, an estimated $18.2K.
- Eli Lilly made up 0.37% of Imprint Wealth's portfolio in Q1 2026, its #47 holding.
- Imprint Wealth first reported a position in Eli Lilly in Q1 2023 and has held it in 8 quarters since.
- Imprint Wealth's Eli Lilly position peaked at $3.25M in Q1 2024.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Imprint Wealth's 13F filing for Q1 2026, filed 15 May 2026.